Escalon Medical Corp.
ESMC · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $12,046 | $11,982 | $12,180 | $10,703 |
| % Growth | 0.5% | -1.6% | 13.8% | – |
| Cost of Goods Sold | $6,535 | $6,835 | $6,699 | $6,096 |
| Gross Profit | $5,511 | $5,146 | $5,481 | $4,607 |
| % Margin | 45.7% | 43% | 45% | 43% |
| R&D Expenses | $753,130 | $688 | $819 | $991 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4,624,711 | $4,562 | $4,184 | $4,086 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$5,372,463 | $0 | $0 | $0 |
| Operating Expenses | $5,378 | $5,251 | $5,003 | $5,077 |
| Operating Income | $133 | -$104 | $479 | $36 |
| % Margin | 1.1% | -0.9% | 3.9% | 0.3% |
| Other Income/Exp. Net | -$28 | -$21 | -$22 | $488 |
| Pre-Tax Income | $106 | -$125 | $457 | $18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $106 | -$125 | $457 | $18 |
| % Margin | 0.9% | -1% | 3.8% | 0.2% |
| EPS | 0.004 | -0.024 | 0.062 | 0.002 |
| % Growth | 115.9% | -138.8% | 2,466.7% | – |
| EPS Diluted | 0.002 | -0.024 | 0.034 | 0.002 |
| Weighted Avg Shares Out | 7,415 | 7,415 | 7,415 | 7,415 |
| Weighted Avg Shares Out Dil | 14,252 | 7,415 | 13,564 | 7,415 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $22,692 | $21 | $22 | $18 |
| Depreciation & Amortization | $38 | $46 | $45 | $328 |
| EBITDA | $166 | -$58 | $524 | $365 |
| % Margin | 1.4% | -0.5% | 4.3% | 3.4% |